Free tool
Diagnostics stocks
We cover 8 companies grouped under the Diagnostics theme. The median market value in the group is $5.11B. Across the group, the median move over the past trading day is −0.29%. Price change over the past year runs from −30.4% to +160.3% across the middle 80 percent of the group, with a median of +29.6%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
8 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.59% |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +21.14% |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.12% |
| CAI | Caris Life Sciences, Inc. | $7.58B | Mid cap | −29.83% |
| CDNA | CareDx, Inc. | $2.64B | Mid cap | +283.45% |
| RIBB | Ribbon Acquisition Corp. | $54.52M | Micro cap | +6.62% |
| PRPO | Precipio, Inc. | $54.43M | Micro cap | +99.25% |
| BIAF | bioAffinity Technologies, Inc. | $3.02M | Micro cap | −31.59% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.